FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
QINLOCK
ripretinib
Peak
Cipher Pharmaceuticals
ORAL · TABLET
2020
SMNDA0/100
QNASL
beclomethasone dipropionate
Peak
Teva
NASAL · AEROSOL, METERED
2012
NDA0/100
QTERNMET XR
dapagliflozin; metformin hydrochloride; saxagliptin hydrochloride
Peak
AstraZeneca
ORAL · TABLET, EXTENDED RELEASE
2019
NDA0/100
QUDEXY XR
topiramate
Peak
ORAL · CAPSULE, EXTENDED RELEASE
2014
NDA0/100
QUILLICHEW ER
methylphenidate hydrochloride
Peak
ORAL · TABLET, EXTENDED RELEASE, CHEWABLE
2015
NDA0/100
QULIPTA
atogepant
Peak
AbbVie
ORAL · TABLET
2021
NDA0/100
QUVIVIQ
daridorexant
Peak
Idorsia
ORAL · TABLET
2022
NDA0/100
QVAR 40
beclomethasone dipropionate
Peak
Teva
INHALATION · AEROSOL, METERED
2000
NDA0/100
QVAR 80
beclomethasone dipropionate
Peak
Teva
INHALATION · AEROSOL, METERED
2000
NDA0/100
QVAR REDIHALER
beclomethasone dipropionate hfa
Peak
INHALATION · AEROSOL, METERED
2017
NDA0/100
RADICAVA ORS
edaravone
Peak
ORAL · SUSPENSION
2022
NDA0/100
RAVICTI
glycerol phenylbutyrate
Peak
Amgen
ORAL · LIQUID
2013
NDA0/100
RAYALDEE
calcifediol
Peak
ORAL · CAPSULE, EXTENDED RELEASE
2016
NDA0/100
RECARBRIO
imipenem anhydrous, cilastatin, and relebactam anhydrous
Peak
Merck & Co.
INTRAVENOUS · POWDER
2019
NDA0/100
RECORLEV
levoketoconazole
Peak
Bridge Therapeutics
ORAL · TABLET
2021
SMNDA0/100
RELEXXII
methylphenidate hydrochloride
Peak
ORAL · TABLET, EXTENDED RELEASE
2022
NDA0/100
RELISTOR
methylnaltrexone bromide
Peak
Salix Pharmaceuticals
ORAL · TABLET
2016
NDA0/100
RELYVRIO
sodium phenylbutyrate; taurursodiol
Peak
Amylyx Pharmaceuticals
ORAL · FOR SUSPENSION
2022
NDA0/100
RESTASIS
cyclosporine
Peak
AbbVie
OPHTHALMIC · EMULSION
2002
NDA0/100
RESTASIS MULTIDOSE
cyclosporine
Peak
AbbVie
OPHTHALMIC · EMULSION
2002
NDA0/100
RETEVMO
selpercatinib
Peak
Eli Lilly and Company
ORAL · CAPSULE
2020
SMNDA0/100
REXULTI
brexpiprazole
Peak
Otsuka
ORAL · TABLET
2015
SMNDA0/100
REYVOW
lasmiditan
Peak
Eli Lilly and Company
ORAL · TABLET
migraine
2019
NDA0/100
REZLIDHIA
olutasidenib
Peak
Rigel Pharmaceuticals
ORAL · CAPSULE
2022
SMNDA0/100